Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lymphoma, B-Cell, Marginal Zone
×
Interleukin-2
×
Clear all
Filters
3
NCT05336409
2025-12-18
ELiPSE-1
Century Therapeutics, Inc.
Phase 1
Terminated
28 enrolled